ASP3652: Clinical Trials

2 trials of ASP3652, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2

Follow ASP3652: new trials by email Literature Review of ASP3652 trials Research Report on ASP3652

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Randomized Study Comparing Placebo and ASP3652 in the Treatment of Women With Bladder Pain Syndrome / Interstitial Cystitis (BPS/IC)
ASP3652, Placebo - Cystitis, Interstitial, Urinary Bladder Disease
Phase 2CompletedAstellas Pharma Europe B.V.2872012-05-312024-11-05
A Clinical Study to Investigate the Efficacy, Safety and Pharmacokinetics of ASP3652 in Patients With Chronic Abacterial Prostatitis / Chronic Pelvic Pain Syndrome (CP/CPPS)
ASP3652, Placebo - Chronic Abacterial Prostatitis, Chronic Pelvic Pain Syndrome
Phase 2CompletedAstellas Pharma Inc2392011-06-012013-03-21

Conditions studied

Bronchiolitis Obliterans Syndrome (1)  ·  Cystitis, Interstitial (1)  ·  Pain (1)  ·  Pelvic Pain (1)  ·  Prostatitis (1)  ·  Urinary Bladder Diseases (1)  ·  Urologic Diseases (1)

Sponsors

Astellas Pharma Europe B.V. (1)  ·  Astellas Pharma Inc (1)

Countries

Czechia (2)  ·  Germany (2)  ·  Latvia (2)  ·  Lithuania (2)  ·  Poland (2)  ·  Spain (2)  ·  Belgium (1)  ·  Denmark (1)  ·  Netherlands (1)  ·  Portugal (1)  ·  Romania (1)  ·  Russia (1)

Results publications

PMID 30178528